KLP Kapitalforvaltning AS acquired a new stake in DaVita Inc. (NYSE:DVA - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 28,314 shares of the company's stock, valued at approximately $4,234,000.
Several other institutional investors have also added to or reduced their stakes in the business. SBI Securities Co. Ltd. purchased a new stake in shares of DaVita during the fourth quarter valued at $41,000. Quarry LP purchased a new stake in shares of DaVita during the 3rd quarter valued at about $60,000. Venturi Wealth Management LLC boosted its holdings in shares of DaVita by 59.8% during the 4th quarter. Venturi Wealth Management LLC now owns 406 shares of the company's stock valued at $61,000 after acquiring an additional 152 shares during the last quarter. Versant Capital Management Inc raised its holdings in shares of DaVita by 58.7% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company's stock valued at $68,000 after purchasing an additional 169 shares during the last quarter. Finally, Blue Trust Inc. lifted its position in DaVita by 39.7% during the fourth quarter. Blue Trust Inc. now owns 461 shares of the company's stock valued at $76,000 after purchasing an additional 131 shares during the period. 90.12% of the stock is currently owned by hedge funds and other institutional investors.
DaVita Stock Performance
DaVita stock traded down $2.21 during midday trading on Friday, hitting $150.29. The stock had a trading volume of 614,947 shares, compared to its average volume of 808,883. The company has a market capitalization of $12.02 billion, a PE ratio of 13.99, a P/E/G ratio of 1.07 and a beta of 0.99. DaVita Inc. has a 52-week low of $125.64 and a 52-week high of $179.60. The firm's fifty day moving average is $157.39 and its two-hundred day moving average is $157.55. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18.
DaVita (NYSE:DVA - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. On average, research analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.
Wall Street Analyst Weigh In
DVA has been the subject of a number of research reports. StockNews.com lowered shares of DaVita from a "buy" rating to a "hold" rating in a research note on Friday, March 21st. Barclays upped their price objective on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 18th. Sanford C. Bernstein set a $184.00 price target on DaVita in a research note on Friday, February 21st. Finally, Cowen reaffirmed a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company. According to MarketBeat, DaVita has an average rating of "Hold" and an average price target of $166.33.
View Our Latest Research Report on DaVita
DaVita Company Profile
(
Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
Further Reading

Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.